Nanobiotix
NANO | PA
Overview
Corporate Details
- ISIN(s):
- FR0010102145 (+2 more)
- LEI:
- 969500667RSYIH8YL895
- Country:
- France
- Address:
- 60 RUE DE WATTIGNIES, 75012 PARIS
- Website:
- https://www.nanobiotix.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. Nanobiotix’s novel first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Furthermore, Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 110.8 KB | |
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.0 KB | |
| 2025-05-21 22:15 |
Earnings Release
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
|
English | 173.9 KB | |
| 2025-05-21 22:15 |
Earnings Release
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du p…
|
French | 194.9 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS C…
|
French | 110.7 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.2 KB | |
| 2025-05-12 08:00 |
Regulatory News Service
Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwri…
|
French | 91.9 KB | |
| 2025-05-12 08:00 |
Regulatory News Service
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investo…
|
English | 89.3 KB | |
| 2025-05-05 08:00 |
Earnings Release
NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1…
|
French | 150.4 KB | |
| 2025-05-05 08:00 |
Earnings Release
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1…
|
English | 140.8 KB | |
| 2025-04-30 08:00 |
Regulatory News Service
Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1…
|
French | 131.2 KB | |
| 2025-04-30 08:00 |
Earnings Release
Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study …
|
English | 119.0 KB | |
| 2025-04-14 22:15 |
Declaration of Voting Results & Voting Rights Announcements
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS C…
|
French | 122.8 KB | |
| 2025-04-14 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 116.7 KB | |
| 2025-04-02 22:49 |
Registration Form
Document d'Enregistrement Universel
|
French | 14.9 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Other | Other | 959,060 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |